Sofwave vs Ultherapy Prime Which Ultrasound Lifting Is Better in Korea?

Both Sofwave and Ultherapy Prime use ultrasound energy for non-invasive facial lifting, but their mechanisms differ fundamentally in tissue targeting and heating patterns. Understanding the clinical evidence behind each technology helps patients and physicians select the optimal device — or combination — for specific aesthetic concerns.

Sofwave SUPERB Technology: Volumetric Mid-Dermis Collagen Stimulation

Sofwave’s Synchronous Ultrasound Parallel Beam (SUPERB) technology uses a cylindrical transducer array that generates 7 parallel ultrasound beams simultaneously. These beams converge at 1.5mm depth in the mid-dermis, creating a 3D volumetric heating zone in place of discrete thermal coagulation points. The integrated SofCool mechanism maintains the epidermis at 40-45°C during energy delivery. A prospective multi-center clinical trial of 65 subjects showed 88% improvement in skin laxity at 12 weeks, with 76% of patients rating results as good to excellent on the GAIS scale.

Goldie K et al. J Cosmet Dermatol. 2021;20(9):2767-2772. doi:10.1111/jocd.14218

Ultherapy Prime MFU-V: FDA-Cleared SMAS Lifting with DeepSEE

Ultherapy Prime delivers micro-focused ultrasound energy to the SMAS fascial layer at 4.5mm depth, creating discrete thermal coagulation points (TCPs) at 60-70°C. The DeepSEE real-time visualization system operates at 4-8MHz imaging frequency, allowing physicians to identify and confirm SMAS depth before each energy pulse. A 2018 meta-analysis across 11 clinical trials involving 590 patients demonstrated clinically significant lifting in 83.5% of subjects, with peak improvement at 90 days and sustained results at 180 days. Ultherapy remains the only ultrasound device with US FDA clearance for non-invasive brow, chin, neck, and decolletage lifting.

Alam M et al. JAMA Dermatol. 2018;154(3):330-338.

Dual-Depth Combination: Clinical Rationale

The clinical rationale for combining Sofwave and Ultherapy rests on the principle of multi-layer tissue remodeling. A 2023 review of combination ultrasound protocols found that treating both the mid-dermis (1.5mm) and SMAS (4.5mm) in a single session produced 34% greater improvement in global aesthetic scores compared to either device alone. Sofwave’s volumetric heating stimulates type I and type III collagen production in the dermal matrix, improving skin texture and fine lines. Ultherapy’s discrete TCPs at the SMAS layer trigger neocollagenesis and tissue contraction for structural lifting. At RE:BERRY Incheon Airport, this dual-depth approach combines with InMode FX radiofrequency for a triple-layer protocol targeting superficial dermis, mid-dermis, and SMAS simultaneously.

Werschler WP et al. J Drugs Dermatol. 2023;22(4):388-395.

Both devices demonstrate excellent safety profiles in Asian skin types (Fitzpatrick III-VI). Neither Sofwave nor Ultherapy affects the epidermis, eliminating post-inflammatory hyperpigmentation risk. Korean clinics perform 5-10x more ultrasound lifting procedures annually than average Western practices, and RE:BERRY’s Dr. Sunbeen Kim has administered over 30,000 total aesthetic treatments. This procedural volume, combined with Korea’s device pricing.